Skip to main content
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · XENE ISIN · CA98420N1050 LEI · 549300XV44Q9Z1MIPQ03 US Manufacturing
Open in API
Filings indexed 746 across all filing types
Latest filing 2022-08-09 Earnings Release
Country CA Canada
Listing US XENE

About Xenon Pharmaceuticals Inc.

https://www.xenon-pharma.com/

Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text indicates that the company announced its financial results for the three and six months ended June 30, 2022, via a press release attached as an exhibit. The document explicitly states that the information is "furnished to, but not filed with" the SEC, and the press release is attached as Exhibit 99.1. The document length is 3410 characters, which is relatively short and mainly serves as an announcement of the earnings release rather than containing the financial results themselves. According to the rules, such a document is best classified as an Earnings Release (ER) because it announces quarterly financial results highlights, even though the full financial details are in the press release exhibit. The Form 8-K is commonly used for earnings releases. Therefore, the classification is ER with high confidence.
2022-08-09 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-29 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-29 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-29 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-29 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-29 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.